INTRODUCTION
============

Heterogeneous ribonucleoprotein Q, isoform 1 (hnRNP-Q1 \[ [@B52]\], Nsap1/Syncrip/hnRNP-Q2 \[ [@B34]; [@B51]; [@B71]\]) is a ubiquitous mRNA-binding protein that demonstrates high expression in the brain ([@B51]; [@B61]; [@B80]). It contains two different RNA-binding domains, three RNA recognition motifs, and a single arginine- and glycine-rich region (RGG box) ([@B52]). hnRNP-Q1 participates in several mRNA processing events, including splicing, editing, transport, translation, and decay ([@B79]). Unlike other hnRNP-Q isoforms, hnRNP-Q1 is mainly localized to the cytoplasm, suggesting that functions in mRNA translation, localization, and/or decay regulation are of higher importance ([@B52]). Supporting this, hnRNP-Q1 has recently been demonstrated to repress *RhoA* mRNA translation and regulate *Cdc42* mRNA localization ([@B14]; [@B80]). Given the high expression of hnRNP-Q1 in brain, we predict that hnRNP-Q1 posttranscriptionally regulates the expression of many mRNA targets, which are potentially involved in neuronal development and function.

GAP-43 is a neuronal-specific protein that regulates multiple aspects of neuronal development, plasticity, and regeneration ([@B21]). GAP-43 is enriched in axonal growth cones after polarity is established and also accumulates along nascent axons in cultured hippocampal neurons, suggesting an important early role for GAP-43 in axon outgrowth ([@B30]). GAP-43 regulates actin dynamics by at least two distinct mechanisms: actin polymerization/depolymerization and sequestering the lipid modulator phosphatidylinositol 4,5-bisphosphate ([@B35]; [@B43]). GAP-43 overexpression is generally associated with increased growth in neurons ([@B2]; [@B24], [@B23]; [@B44]), and the importance of GAP-43 is demonstrated by impaired neuronal development and axon guidance in GAP-43--deficient mice ([@B25]; [@B65]; [@B46]; [@B70]). GAP-43 also plays an important role in neuronal regeneration, with increased GAP-43 expression observed during regeneration ([@B27]; [@B75]) and increased GAP-43 protein levels promoting axon sprouting and regeneration after injury and vice versa ([@B12]; [@B63]; [@B4]; [@B31]; [@B3]). Additionally, GAP-43 is required for proper learning and memory formation ([@B60]; [@B36]), and altered expression of GAP-43 is linked to brain disease ([@B19]; [@B10]; [@B73]; [@B82]). These critical functions of GAP-43 motivate a better understanding of how the expression of this protein is regulated.

Precise spatial and temporal control of GAP-43 protein levels is achieved through multiple mechanisms and is critical for GAP-43 function. The *Gap-43* gene is transcribed exclusively in neuronal cells due to a repressive element in its promoter region ([@B77]) and specific transcription factors ([@B15]; [@B22]; [@B72]). *Gap-43* mRNA stability is increased by HuD, a neuronal ELAV family mRNA-binding protein, binding the 3′-UTR ([@B16]; [@B5]) and decreased by KSRP, a KH-type splicing regulatory protein, competing with HuD for binding ([@B9]). Also, *Gap-43* mRNA localization to dorsal root ganglia axons is regulated by the mRNA-binding protein IMP1/ZBP1 ([@B24]). *Gap-43* mRNA translation is also likely regulated as an additional mechanism to control GAP-43 expression, but the factors involved have not been identified. In this paper, we show that hnRNP-Q1 inhibits primary cortical neuron nascent axon length, total neurite length and neurite number, and Neuro2a (N2a) cell process extension by repressing GAP-43 expression. hnRNP-Q1 specifically represses *Gap-43* mRNA translation, and a G-quadruplex (GQ) structure in the 5′-UTR of the mRNA is involved in the mechanism. Therefore our findings reveal a novel posttranscriptional mechanism for regulating GAP-43 expression that may contribute to the precise control of GAP-43 expression during neuronal development.

RESULTS
=======

Two model systems were used for our experiments, the mouse neuroblastoma cell line N2a and primary mouse cortical neurons, as a means to assess multiple aspects of hnRNP-Q1--mediated repression of *Gap-43* mRNA translation. N2a cells are an ideal neuronal model system, because they are highly amenable to biochemical experiments and can be differentiated into neuron-like cells ([@B40]; [@B54]). Primary cortical neurons were used due to high expression of hnRNP-Q1 in the forebrain ([@B51]; [@B61]; [@B80]). Cultured primary cortical neurons differentiate axons and dendrites and undergo neuronal differentiation ([@B41]), and we have used them previously to examine early stages of axon outgrowth ([@B78]).

Elevated GAP-43 expression in hnRNP-Q1--deficient N2a cells and cortical neurons
--------------------------------------------------------------------------------

We first sought to determine whether GAP-43 protein levels were affected by hnRNP-Q1 knockdown, because GAP-43 is an important neuronal protein and hnRNP-Q1 is highly expressed in the brain. N2a cells were transfected with hnRNP-Q1 small interfering RNAs (siRNAs) targeting sequences in the 3′ untranslated region (3′-UTR) that are not present in other hnRNP-Q isoforms. Scrambled (Scr) siRNA was used as a control. Immunoblot analysis of cell lysates 72 h after transfection revealed that hnRNP-Q1 can be efficiently depleted (siRNA 1 = 0.31-fold, siRNA 2 = 0.44-fold, and siRNA 3 = 0.67-fold; [Figure 1A](#F1){ref-type="fig"}). Interestingly, GAP-43 protein levels were increased according to the degree of hnRNP-Q1 depletion (siRNA 1 = 2.99-fold, siRNA 2 = 2.30-fold, and siRNA 3 = 1.72-fold; [Figure 1A](#F1){ref-type="fig"}). The levels of the highly homologous proteins hnRNP-R and hnRNP-Q3 and γ-actin protein were not significantly affected ([Figure 1A](#F1){ref-type="fig"}). hnRNP-Q1 siRNA 1 was used for the remainder of the experiments, because it demonstrated the greatest knockdown. Quantitative real time-PCR (qRT-PCR) was performed to determine whether hnRNP-Q1 knockdown affects *Gap-43* mRNA levels. We found that neither *Gap-43* nor *γ-actin* mRNA levels were significantly altered upon hnRNP-Q1 knockdown (1.02-fold and 1.05-fold, respectively; [Figure 1B](#F1){ref-type="fig"}) suggesting that hnRNP-Q1 may regulate GAP-43 expression through a translational mechanism.

![Increased GAP-43 protein expression upon hnRNP-Q1 knockdown. (A) GAP-43 and γ-actin protein levels were assessed by immunoblot in N2a cell lysates 72 h after hnRNP-Q1 \#1, hnRNP-Q1 \#2, hnRNP-Q1 \#3, or Scr siRNA transfection. *n* = 6, one-way analysis of variance (ANOVA), Dunnett's posthoc, hnRNP-R *p* values: Scr vs. Q1 \#1, *p* = 0.3897; Scr vs. Q1 \#2, *p* = 0.2057; Scr vs. Q1 \#3, *p* = 0.1801; hnRNP-Q3 *p* values: Scr vs. Q1 \#1, *p* = 0.8869; Scr vs. Q1 \#2, *p* = 0.4025; Scr vs. Q1 \#3, *p* = 0.8486; hnRNP-Q1 *p* values: Scr vs. Q1 \#1, *p* \< 0.0001; Scr vs. Q1 \#2, *p* \< 0.0001; Scr vs. Q1 \#3, *p* = 0.0002; GAP-43 *p* values: Scr vs. Q1 \#1, *p* \< 0.0001; Scr vs. Q1 \#2, *p* \< 0.0001; Scr vs. Q1 \#3, *p* = 0.0163; γ-actin *p* values: Scr vs. Q1 \#1, *p* = 0.8493; Scr vs. Q1 \#2, *p* = 0.3335; Scr vs. Q1 \#3, *p* = 0.9995. (B) *Gap-43* and *γ-actin* mRNA levels were assessed by qRT-PCR in N2a cell lysates 72 h after hnRNP-Q1 \#1 or Scr siRNA transfection. *n* = 6, one-sample *t* test, *p* values: *Gap-43*, *p* = 0.6415; *γ-actin*, *p* = 0.8956. (C--G) Primary cortical neurons were transfected with hnRNP-Q1 \#1 or Scr siRNA + Lifeact-GFP by nucleofection and cultured for 28.5 h. GAP-43 and hnRNP-Q1 were detected by immunofluorescence, and GFP-positive cells were imaged. (C) Representative images with inset heat maps and (D) enlarged views of the nascent axon with a GAP-43 heat map (white boxes in C). Scale bars: 10 μm. Quantification of GAP-43 and hnRNP-Q1 signal intensity in (E) cell bodies and (F) the nascent axon. *n* = 6, Scr: 198 neurons and Q1: 178 neurons from six independent experiments, one-sample *t* test, cell body *p* values: hnRNP-Q1, *p* \< 0.0001; GAP-43, *p* = 0.0002; nascent axon *p* values: hnRNP-Q1, *p* = 0.2044; GAP-43, *p* \< 0.0001. (G) Ratio of nascent axon/cell body GAP-43 protein levels. *n* = 6, Scr: 198 neurons and Q1: 178 neurons from six independent experiments, one-sample *t* test, *p* value = 0.0002.](518fig1){#F1}

Primary cortical neurons were also assessed to determine whether hnRNP-Q1 depletion increases GAP-43 protein expression at the subcellular level. Neurons were electroporated with hnRNP-Q1 \#1 or Scr siRNA and Lifeact--green fluorescent protein (GFP) immediately following the dissection and were fixed after 28.5 h in culture. siRNA was used instead of short hairpin RNA (shRNA) due to higher transfection efficiencies and quicker knockdown times, which are required to assess incipient neuron phenotypes. The neurons were then processed for immunofluorescence with GAP-43 and hnRNP-Q1 antibodies, and transfected cells were selected by GFP signal ([Figure 1, C and D](#F1){ref-type="fig"}). The specificity of the hnRNP-Q1 antibody was verified by immunoblotting N2a cell lysates after overexpressing EGFP-tagged hnRNP-Q1 for ∼16 h (Supplemental Figure 1A). Because GAP-43 is enriched in axonal growth cones after polarity is established, we quantified GAP-43 protein levels in both the cell bodies and nascent axons of these incipient neurons. hnRNP-Q1 knockdown increased GAP-43 protein levels on average by 1.36-fold in cells bodies and by 1.56-fold in nascent axons ([Figure 1, E and F](#F1){ref-type="fig"}). Plotting hnRNP-Q1 protein levels against GAP-43 protein levels for each cell supports an inverse correlation between hnRNP-Q1 and GAP-43 protein levels (Supplemental Figure 1B). hnRNP-Q1 knockdown also did not reduce the ratio of GAP-43 levels in nascent axon/cell body, suggesting that hnRNP-Q1 is not required for GAP-43 protein enrichment in the nascent axon and growth cone ([Figure 1G](#F1){ref-type="fig"}). In fact, the nascent axon/cell body ratio was actually significantly increased upon hnRNP-Q1 knockdown (0.73--0.83, 1.14-fold) suggesting that hnRNP-Q1 negatively regulates GAP-43 levels within the axon ([Figure 1G](#F1){ref-type="fig"}).

An inverse correlation between hnRNP-Q1 and GAP-43 protein levels would support our model that hnRNP-Q1 negatively regulates GAP-43 protein expression. Thus we investigated the expression profiles of hnRNP-Q1 and GAP-43 in cultured neurons. High-density primary cortical neurons were cultured for 0--21 d, and cell lysates were collected every third day and immunoblotted for hnRNP-Q1 and GAP-43. The expression profiles from the time course suggest that hnRNP-Q1 and GAP-43 are both developmentally regulated in primary cortical neurons and that these proteins have opposite patterns. hnRNP-Q1 protein levels decreased over time, while GAP-43 protein levels increased, suggesting that the decreasing levels of hnRNP-Q1 may contribute to the increasing levels of GAP-43 in primary cortical neurons (Supplemental Figure 1C). Additionally, GAP-43 and the mRNA-binding protein HuD, a positive regulator of GAP-43 expression, have previously been demonstrated to be enriched in Ammon's horn as compared with the dentate gyrus of the hippocampus in vivo ([@B17]; [@B56]). Therefore we assessed whether hnRNP-Q1, a proposed negative regulator of GAP-43 expression, demonstrated the opposite pattern of expression. The two regions of the hippocampus were dissected from P30 wild-type mice ([@B32]), and the levels of *HuD*, *Gap-43*, and *hnRNP-Q1* mRNAs were quantified by qRT-PCR due to an inadequate amount of tissue for immunoblotting. As expected, *HuD* and *Gap-43* mRNAs were enriched in Ammon's horn (2.54-fold and 1.65-fold, respectively; Supplemental Figure 1D). However, *hnRNP-Q1* mRNA was not enriched in the Ammon's horn and is potentially more enriched in the dentate gyrus, suggesting that hnRNP-Q1 expression may contribute to GAP-43 protein expression in vivo in the hippocampus (0.72-fold; Supplemental Figure 1D).

Elevated GAP-43 expression in hnRNP-Q1--deficient cortical neurons increased neurite length and number
------------------------------------------------------------------------------------------------------

The role of GAP-43 in promoting axon growth has been extensively studied ([@B2]; [@B24], [@B23]; [@B44]). Therefore we next determined whether elevated GAP-43 protein levels due to hnRNP-Q1 knockdown affect neurite length and number. To investigate whether hnRNP-Q1 knockdown phenotypes were due to increased GAP-43 protein levels, we performed rescue experiments by knocking down GAP-43. GAP-43 knockdown efficiency was tested by transfecting N2a cells with GAP-43 or Scr siRNA and performing an immunoblot analysis of cell lysates after 72 h. GAP-43 protein levels were efficiently knocked down (91% reduction; Supplemental Figure 2A). Therefore, neurons were electroporated with hnRNP-Q1 \#1 or Scr siRNA and Lifeact-GFP but also with GAP-43 or Scr siRNA to specifically link any phenotypes to increased GAP-43 protein levels. The neurons were fixed after 28.5 h in culture and processed for immunofluorescence with GAP-43 and hnRNP-Q1 antibodies, and transfected cells were selected by GFP signal ([Figure 2A](#F2){ref-type="fig"}).

![Double knockdown of hnRNP-Q1 and GAP-43. Primary cortical neurons were transfected with hnRNP-Q1 \#1 or Scr siRNA, GAP-43 or Scr siRNA and Lifeact-GFP by nucleofection and processed for immunofluorescence with GAP-43 and hnRNP-Q1 antibodies after 28.5 h. (A) Representative images with inset heat maps. Scale bar: 10 μm. (B) Plot of cell body hnRNP-Q1 protein levels against cell body GAP-43 protein levels for each cell. The threshold between low and high levels of each protein was set at 12,500 A.U. as depicted by the black lines. Red outline indicates the cell population with low levels of hnRNP-Q1 and high levels of GAP-43 that was assessed for increased neurite length and number in [Figure 3](#F3){ref-type="fig"} (Q1 siRNA + Scr siRNA cells only). (C) Table showing the correlation between hnRNP-Q1 and GAP-43 protein levels. The percentage of total cells in each category is listed, and the highlighted populations (corresponding to the bar graphs in [Figure 3](#F3){ref-type="fig"}) were analyzed for neurite length and number.](518fig2){#F2}

We performed a single-cell analysis, which consisted of quantifying cell body hnRNP-Q1 and GAP-43 protein levels and measuring nascent axon length, total neurite length, and neurite number. Plotting hnRNP-Q1 protein levels against GAP-43 protein levels for each cell revealed three major expression patterns ([Figure 2B](#F2){ref-type="fig"}): 1) high hnRNP-Q1 and low GAP-43 protein levels, the pattern most prevalent in control and GAP-43 knocked-down cells; [2)](#m2){ref-type="disp-formula"} low hnRNP-Q1 and high GAP-43 protein levels, the pattern most prevalent in hnRNP-Q1 knocked-down cells; and [3)](#m3){ref-type="disp-formula"} low hnRNP-Q1 and low GAP-43 protein levels, a common expression profile in all experimental conditions. The threshold between low and high protein levels for both hnRNP-Q1 and GAP-43 was set at 12,500 A.U. (arbitrary units) based the expression plot ([Figure 2B](#F2){ref-type="fig"}). Analysis of the percent of cells showing each of the three expression patterns illustrates an inverse relationship between hnRNP-Q1 and GAP-43 expression ([Figure 2C](#F2){ref-type="fig"}). In control cells, the majority (51.4%) of neurons had low hnRNP-Q1 and low GAP-43 protein levels, presumably due to multiple factors regulating each protein ([Figure 2C](#F2){ref-type="fig"}). For example, GAP-43 protein turnover may be dynamically regulated, which is supported by the finding that GAP-43 protein is degraded by the ubiquitin--proteasome system ([@B20]). Therefore steady-state GAP-43 protein levels may not increase in some cells upon hnRNP-Q1 knockdown due to high levels of GAP-43 protein turnover, despite the increased *Gap-43* mRNA translation rate. Additionally, cells may be lacking sufficient levels of other factors that are required to result in increased GAP-43 protein levels (e.g., HuD to stabilize *Gap-43* mRNA). Nonetheless, a substantial percentage of cells (35.8%) showed high hnRNP-Q1 and low GAP-43 protein levels under control conditions, consistent with the proposed role of hnRNP-Q1 as a negative regulator of GAP-43 expression ([Figure 2C](#F2){ref-type="fig"}). Depletion of hnRNP-Q1 revealed a marked decrease in cells showing high hnRNP-Q1 and low GAP-43 protein levels (from 35.8 to 4.1%), suggesting removal of GAP-43 repression by hnRNP-Q1 knockdown ([Figure 2C](#F2){ref-type="fig"}). Conversely, knockdown of hnRNP-Q1 resulted in a marked increase in cells with low hnRNP-Q1 and high GAP-43 protein levels (from 4.6 to 27.6%), further suggesting that the elevation in GAP-43 protein levels was directly ­attributed to loss of hnRNP-Q1 ([Figure 2C](#F2){ref-type="fig"}). The phenotype of high GAP-43 protein levels in hnRNP-Q1--depleted cells (27.6%) was abolished by simultaneous knockdown of GAP-43 (1.6%), demonstrating that GAP-43 can be efficiently depleted ([Figure 2C](#F2){ref-type="fig"}). Additionally, knockdown of GAP-43 by itself did not change the negative correlation between hnRNP-Q1 and GAP-43 protein levels, wherein a substantial percentage of cells (32.6%) still showed high hnRNP-Q1 and low GAP-43 protein levels ([Figure 2C](#F2){ref-type="fig"}). Furthermore, a very small percentage of cells had high hnRNP-Q1 and high GAP-43 protein levels (control: 8.1%; GAP-43: 0.6%; hnRNP-Q1: 7.6%; and hnRNP-Q1 & GAP-43: 3.3%).

To determine whether elevated GAP-43 protein levels due to hnRNP-Q1 knockdown affect neurite length and number, we specifically analyzed the cells within the population that exhibited the characteristic expression pattern for each condition (highlighted in [Figure 2C](#F2){ref-type="fig"}; the average hnRNP-Q1 and GAP-43 protein levels of selected cells are displayed in Supplemental Figure 2B). Shortly after being plated (∼6 h), cultured neurons develop lamellipodia that transform into distinct processes after ∼12 h ([@B26]). One of these minor processes is specified to become the axon and begins to grow at an accelerated rate as compared with the remaining processes after ∼1--2 d in culture ([@B26]). Therefore the longest neurite after 28.5 h in culture will likely develop into the axon and was called the "nascent axon" in our studies. The total length and number of all neurites was also quantified. Cells with low levels of GAP-43 protein and high levels of hnRNP-Q1 protein were selected in the control conditions (Scr siRNA + Scr siRNA: 35.8% of cells; Scr siRNA + GAP-43 siRNA: 32.6% of cells); cells with low levels of hnRNP-Q1 protein and high levels of GAP-43 protein were selected in the Q1 siRNA + Scr siRNA condition (27.6% of cells; red outline in [Figure 2B](#F2){ref-type="fig"}); and cells with low levels of both proteins were selected in the Q1 siRNA + GAP-43 siRNA condition (78.8% of cells). Neurons with elevated GAP-43 protein levels following hnRNP-Q1 knockdown correlated with an increased length of the nascent axon by 1.44-fold (31.00 to 44.76 μm; [Figure 3, A and D](#F3){ref-type="fig"}), total length of all the neurites by 1.66-fold (86.11 to 143.12 μm; [Figure 3, B and E](#F3){ref-type="fig"}), and number of neurites per cell by 1.44-fold (4.84 to 6.96 neurites, [Figure 3, C and F](#F3){ref-type="fig"}). Additionally, simultaneously knocking down GAP-43 rescued all three phenotypes back to control levels, which demonstrates that increased GAP-43 protein levels are responsible for the neuritic and axonal phenotypes in hnRNP-Q1--deficient neurons ([Figure 3, A--F](#F3){ref-type="fig"}). The nascent axon length, total neurite length, and neurite number of Q1 siRNA + Scr siRNA cells with low levels of hnRNP-Q1 protein and low levels of GAP-43 protein (60.6% of cells) were also quantified to confirm that GAP-43 is driving the increased neurite growth. The average nascent axon length (1.03-fold, *p* value = 0.9745), total neurite length (0.91-fold, *p* value = 0.8029), and neurite number (0.83-fold, *p* value = 0.3102) were not significantly altered as compared with control Scr siRNA + Scr siRNA cells (unpublished data). These results support our model that increased axon growth in hnRNP-Q1--depleted cells is attributed to elevated GAP-43 expression.

![Increased cortical neuron nascent axon length, total neurite length, and neurite number due to increased GAP-43 protein expression upon hnRNP-Q1 knockdown. (A) Average nascent axon length, (B) total neurite length, and (C) neurite number of selected neurons from [Figure 2](#F2){ref-type="fig"} were quantified. *n* = 7, Scr + Scr: 62 out of 173 cells; Scr + GAP-43: 59 out of 181 cells; Q1 + Scr: 47 out of 170 cells; and Q1 + GAP-43: 145 out of 184 cells from seven independent experiments. One-way ANOVA, Tukey's posthoc, nascent axon length *p* values: Scr + Scr vs. Scr + GAP-43, *p* = 0.8423; Scr + Scr vs. Q1 + Scr, *p* = 0.0004; Scr + Scr vs. Q1 + GAP-43, *p* = 0.5784; Scr + GAP-43 vs. Q1 + Scr, *p* \< 0.0001; Scr + GAP-43 vs. Q1 + GAP-43, *p* = 0.9921; Q1 + Scr vs. Q1 + GAP-43, *p* \< 0.0001; total neurite length *p* values: Scr + Scr vs. Scr + GAP-43, *p* = 0.9884; Scr + Scr vs. Q1 + Scr, *p* \< 0.0001; Scr + Scr vs. Q1 + GAP-43, *p* = 0.2956; Scr + GAP-43 vs. Q1 + Scr, *p* \< 0.0001; Scr + GAP-43 vs. Q1 + GAP-43, *p* = 0.5334; Q1 + Scr vs. Q1 + GAP-43, *p* \< 0.0001; neurite number *p* values: Scr + Scr vs. Scr + GAP-43, *p* = 0.9707; Scr + Scr vs. Q1 + Scr, *p* = 0.0021; Scr + Scr vs. Q1 + GAP-43, *p* = 0.4028; Scr + GAP-43 vs. Q1 + Scr, *p* = 0.0098; Scr + GAP-43 vs. Q1 + GAP-43, *p* = 0.1699; Q1 + Scr vs. Q1 + GAP-43, *p* \< 0.0001. (D--F) Cumulative distribution plots for each measurement of selected neurons from [Figure 2](#F2){ref-type="fig"}.](518fig3){#F3}

Elevated GAP-43 expression in hnRNP-Q1--deficient N2a cells increased process extension
---------------------------------------------------------------------------------------

We next determined whether hnRNP-Q1 knockdown also affects the morphology of N2a cells. N2a cells were transfected with hnRNP-Q1 \#1 or Scr siRNA, GAP-43 or Scr siRNA and Lifeact-GFP and fixed after 72 h. The cells were then processed for immunofluorescence with GAP-43 and hnRNP-Q1 antibodies, and transfected cells were selected by GFP signal ([Figure 4A](#F4){ref-type="fig"}). Cells were categorized based on their degree of process extension (Supplemental Figure 3A). hnRNP-Q1 knockdown significantly increased the proportion of cells with processes as compared with control cells (cat. 2 = 21.7%, cat. 3 = 12.3%, cat. 4 = 4.5%, and cat. 2 = 12.7%, cat. 3 = 2.6%, cat. 4 = 0.3%, respectively; [Figure 4B](#F4){ref-type="fig"}). Additionally, simultaneously knocking down GAP-43 partially rescued this phenotype (cat. 2 = 21.1%, cat. 3 = 6.9%; and cat. 4 = 0.8%; [Figure 4B](#F4){ref-type="fig"}), suggesting that repression of GAP-43 expression contributes to hnRNP-Q1--mediated inhibition of N2a cell process extension and, potentially, differentiation. Interestingly, the cell media needed to be changed frequently to rescue this phenotype, and N2a cells transfected with just hnRNP-Q1 \#1 shRNA demonstrated enhanced process extension as compared with control cells (cat. 2 = 27.71%, cat. 3 = 35.67%, and cat. 4 = 18.79%, and Cat 2. = 28.2%, Cat 3. = 15.7%, and cat. 4 = 3.2%, respectively; Supplemental Figure 3B), suggesting that hnRNP-Q1 depletion leads to increased secretion of growth factors.

![Increased N2a cell process extension due to increased GAP-43 protein expression upon hnRNP-Q1 knockdown. N2a cells were transfected with hnRNP-Q1 \#1 or Scr siRNA, GAP-43 or Scr siRNA and Lifeact-GFP and processed for immunofluorescence with GAP-43 and hnRNP-Q1 antibodies after 72 h. Cells were then imaged and categorized based on their degree of process extension (see Supplemental Figure 3A). (A) Representative images with heat maps. Scale bar: 10 *μ*m. (B) Quantification of the results. Percent of cells in each category: Scr + Scr: cat. 1 = 84.4%; cat. 2 = 12.7%; cat. 3 = 2.6%; cat. 4 = 0.3%; Scr + GAP-43: cat. 1 = 71.6%; cat. 2 = 21.3%; cat. 3 = 6.7%; cat. 4 = 0.4%; Q1 + Scr: cat. 1 = 61.5%; cat. 2 = 21.7%; cat. 3 = 12.3%; cat. 4 = 4.5%; Q1 + GAP-43: cat. 1 = 71.2%; cat. 2 = 21.1%; cat. 3 = 6.9%; cat. 4 = 0.8%. *n* = 4, Scr + Scr: 379 cells; Scr + GAP-43: 239 cells; Q1 + Scr: 286 cells; and Q1 + GAP-43: 261 cells from four independent experiments. Kruskal-Wallis test, Dunn's posthoc, *p* values: Scr + Scr vs. Scr + GAP-43, *p* = 0.0029; Scr + Scr vs. Q1 + Scr, *p* \< 0.0001; Scr + Scr vs. Q1 + GAP-43, p = 0.0013; Scr + GAP-43 vs. Q1 + Scr, *p* = 0.0137; Scr + GAP-43 vs. Q1 + GAP-43, *p* \> 0.9999; Q1 + Scr vs. Q1 + GAP-43, *p* = 0.0156.](518fig4){#F4}

hnRNP-Q1 directly binds a GQ sequence in the 5′-UTR of the *Gap-43* mRNA through the RGG box
--------------------------------------------------------------------------------------------

To investigate a possible translational mechanism for how hnRNP-Q1 represses GAP-43 expression, we first determined whether hnRNP-Q1 interacts with endogenous *Gap-43* mRNA. We overexpressed 3×Flag-mCherry-hnRNP-Q1 in N2a cells, and hnRNP-Q1 was immunoprecipitated with anti-Flag agarose beads. Copurifying mRNAs were assessed by qRT-PCR and normalized to levels of the non hnRNP-Q1 target *γ-actin* mRNA. *Gap-43* mRNA was significantly enriched (2.89-fold) in hnRNP-Q1 pellets as compared with *γ-actin* mRNA but not *Gapdh* mRNA (1.07-fold), suggesting that hnRNP-Q1 forms a complex with *Gap-43* mRNA ([Figure 5A](#F5){ref-type="fig"}). Biotin pull-down experiments were performed to test whether hnRNP-Q1 directly interacts with *Gap-43* mRNA and to identify the *Gap-43* mRNA sequences that are required for hnRNP-Q1 binding. Biotinylated probes corresponding to the *Gap-43* 5′-UTR, coding region and 3′-UTR were in vitro transcribed along with the *γ-actin* 3′-UTR as a negative control ([Figure 5B](#F5){ref-type="fig"}). Equimolar concentrations of the RNA probes were incubated with recombinant glutathione *S*-transferase (GST) or GST-hnRNP-Q1 protein, and the probes were precipitated with NeutrAvidin agarose beads. Copurifying protein was assessed by GST immunoblot. GST-hnRNP-Q1 but not GST was precipitated with probes corresponding to all three regions of the *Gap-43* mRNA but not with the *γ-actin* 3′-UTR probe ([Figure 5C](#F5){ref-type="fig"}), demonstrating that hnRNP-Q1 directly interacts with *Gap-43* mRNA. Interestingly, we observed that the 5′-UTR precipitated the most GST-hnRNP-Q1, followed by the coding region, and then the 3′-UTR ([Figure 5C](#F5){ref-type="fig"}). Thus we focused our analysis on a predicted GQ sequence in the 5′-UTR region of *Gap-43* mRNA, because these structures have previously been demonstrated to repress translation ([@B11]). The predicted GQ sequence that we assessed had the highest G-Score of all predicted GQs in mouse *Gap-43* mRNA (G-Score = 42, QGRS Mapper \[ [@B39]\]; Supplemental Figure 4A). Human *Gap-43* mRNA also has a predicted GQ with a high G-Score in the 5′-UTR, suggesting a conserved mechanism (G-Score = 36, QGRS Mapper \[ [@B39]\]; Supplemental Figure 4B). We observed that deleting the *Gap-43* 5′-UTR GQ sequence (5′GQ, 5′-GGGAGGGAGGGAGGGA-3′) almost completely abolished GST-hnRNP-Q1 binding to the 5′-UTR (reduced by 88%; [Figure 5C](#F5){ref-type="fig"}). Because hnRNP-Q1 appears to bind to multiple regions of the *Gap-43* mRNA, we next determined whether deleting the 5′GQ affects hnRNP-Q1 binding to full-length (FL) *Gap-43* mRNA. Biotinylated probes corresponding to FL *Gap-43* mRNA with and without the 5′GQ were in vitro transcribed ([Figure 5B](#F5){ref-type="fig"}) and used for biotin pull-down experiments. Deleting the 5′GQ reduced GST-hnRNP-Q1 binding to FL *Gap-43* mRNA by 41%, suggesting that this sequence is a major hnRNP-Q1--binding site ([Figure 5D](#F5){ref-type="fig"}). Additionally, GST-hnRNP-Q1 binds to the 5′GQ better than to either a 12-nucleotide or 30-nucleotide poly(A) probe (Supplemental Figure 4C). These results suggest that the 5′GQ is a major hnRNP-Q1--binding site and that the 5′GQ and not the poly(A) tail are involved in hnRNP-Q1--mediated GAP-43 regulation as predicted by the results from [@B71].

![hnRNP-Q1 directly binds a *Gap-43* 5′-UTR GQ sequence through the RGG box. (A) Flag-tagged hnRNP-Q1 was immunoprecipitated from N2a cell lysates, and copurified endogenous mRNAs were assessed by qRT-PCR. *n* = 3, one-way ANOVA, Dunnett's posthoc, *p* values: *Gapdh*, *p* = 0.9276; *Gap-43*, *p* = 0.0002. (B) Biotinylated RNA probes corresponding to FL *Gap-43* mRNA, specific *Gap-43* mRNA sequences, and/or deletions, or the *γ-actin* 3′-UTR were in vitro transcribed (see C and D for RNA probe purity). The (C) subregion or (D) FL RNA probes were incubated with recombinant GST or GST-hnRNP-Q1 protein and precipitated with NeutrAvidin beads. Copurified protein was assessed by GST immunoblot. Relative band intensity is listed below the immunoblots, and RNA probe integrity is shown by formaldehyde gel electrophoresis. (E) Representative fluorescence spectroscopy binding curve of the hnRNP-Q1 RGG box peptide and 2AP-labeled *Gap-43* 5′GQ RNA probe complex in 150 mM KCl and in the presence of a fivefold excess of the hepatitis C virus core peptide. The *K*~d~ value determined from triplicate experiments was 131 ± 14 nM.](518fig5){#F5}

Given that RGG box domains have been demonstrated to specifically bind GQ-forming mRNA sequences ([@B62]; [@B48]; [@B47]; [@B69]), we next determined whether hnRNP-Q1 interacts with the 5′GQ through the RGG box domain. We overexpressed 3×-Flag-mCherry, 3×Flag-mCherry/hnRNP-Q1, 3×Flag-mCherry/hnRNP-Q1 ΔRGG box and 3×Flag-mCherry/hnRNP-Q1 RGG box in N2a cells for ∼16 h. Biotin pull-down experiments were then performed with the 5′GQ probe and the N2a cell lysates. Copurifying protein was assessed by Flag immunoblot. FL hnRNP-Q1 (3×Flag-mCherry/hnRNP-Q1) and the RGG box domain (3x×Flag-mCherry/hnRNP-Q1 RGG Box) both bound the 5′GQ probe, while hnRNP-Q1 lacking the RGG box domain (3×Flag-mCherry/hnRNP-Q1 deltaRGG box) did not (Supplemental Figure 4D). These results demonstrate that the hnRNP-Q1 RGG box is necessary and sufficient to bind the *Gap-43* 5′GQ. We also used fluorescence spectroscopy to determine the binding affinity. We designed a fluorescently labeled *Gap-43* 5′GQ RNA probe in which the adenine at position four was replaced with 2-aminopurine (2AP), which is a highly fluorescent analogue of adenine whose steady-state fluorescence is sensitive to changes in the microenvironment ([@B64]; [@B8]). A sample of 150 nM 2AP-labeled *Gap-43* 5′GQ RNA probe was prepared in 10 mM cacodylic acid buffer (pH 6.5) and 50 nM increments of the hnRNP-Q1 RGG box peptide were titrated while the changes in the steady-state 2AP fluorescence were monitored ([Figure 5E](#F5){ref-type="fig"}). The resulting binding curves were fitted with [Eq. 1](#m1){ref-type="disp-formula"} (*Materials and Methods*) to reveal a dissociation constant (*K*~d~) of 131 ± 14 nM for the complex formed between the *Gap-43* 5′GQ RNA probe and the hnRNP-Q1 RGG box ([Figure 5E](#F5){ref-type="fig"}). These experiments were performed in triplicate, and the reported error represents the SD of the *K*~d~ from the three independent measurements.

The *Gap-43* 5′-UTR GQ sequence folds into a GQ structure
---------------------------------------------------------

We next determined whether the *Gap-43* 5′GQ folds into a GQ structure, as predicted by the GQ prediction software QGRS Mapper ([@B39]). The *Gap-43* 5′GQ probe (with a linker, 5′-GGGAGGGAGGGAGGGA+GAGC-3′) was in vitro transcribed, purified by electrophoresis, and run on a denaturing polyacrylamide gel to verify probe purity (Supplemental Figure 5A). We first analyzed 5′GQ probe folding by 20% nondenaturing polyacrylamide gel with varied KCl ­concentrations (0--150 mM). A single band was observed at all KCl concentrations investigated, indicating that a single GQ conformation was adopted (Supplemental Figure 5B). However, there was a small shift in the band position after KCl was added, which supports potassium-driven stability of the GQ structure (Supplemental Figure 5B).

We then used one-dimensional (1D) ^1^H NMR spectroscopy to analyze imino proton resonances. Imino proton resonances in the 10--12 ppm region have been assigned to guanine imino protons engaged in Hoogsteen base pairs within individual G-quartets and are considered signatures of GQ structure formation ([@B28]; [@B47]; [@B55]). While DNA GQs require the presence of potassium ions for folding, RNA GQs of identical sequence can fold in the absence of these ions but have lower stability ([@B37]). Resonances are present in the 10--12 ppm region even in the absence of KCl, indicating GQ formation within the 5′GQ probe ([Figure 6A](#F6){ref-type="fig"}). The intensity of these resonances increased upon the addition of KCl, demonstrating that the structure is stabilized by K^+^ ions ([Figure 6A](#F6){ref-type="fig"}). A mutant *Gap-43* 5′GQ probe (with a linker, 5′-GCGAGCGAGCGAGCGA+GAGC-3′) was also synthesized, in which guanine nucleotides predicted to be engaged in GQ formation were replaced with cytosine nucleotides, and the secondary structure was analyzed by 1D ^1^H NMR spectroscopy. As expected, the GQ imino proton resonances are no longer present in the 10--12 ppm region in the absence and presence of 150 mM KCl (Supplemental Figure 5C). However, resonances are present in the 12.6--13.4 ppm region that correspond to imino protons involved in G-C Watson-Crick base pairs, consistent with the predicted hairpin structure of the *Gap-43* 5′GQ mutant RNA probe (Supplemental Figure 5, C and D). This result confirms that mutation of the guanine nucleotides abolishes GQ structure formation, suggesting that *Gap-43* 5′GQ structure formation is required for hnRNP-Q1 binding.

![The *Gap-43* 5′-UTR GQ sequence folds into a stable, parallel, intramolecular GQ Structure. (A) 1D ^1^H NMR spectroscopy with the *Gap-43* 5′GQ RNA probe revealed that imino proton resonances are present in the 10--12 ppm region even in the absence of KCl. (B) CD spectra of the *Gap-43* 5′GQ RNA probe in the presence of increasing KCl concentrations were acquired, and the results fitted the signature parallel GQ curve (negative peak at ∼240 nm and a positive peak at ∼265 nm). (C) UV spectroscopy thermal denaturation of the *Gap-43* 5′GQ RNA probe. Inset: fit of the main hypochromic transition present in the UV thermal denaturation profile of the *Gap-43* 5′GQ RNA probe with [Eq. 4](#m4){ref-type="disp-formula"} (*Materials and Methods*) from which the following thermodynamic parameters were determined: Δ*H*^o^ = −64.3 ± 0.1 kcal/mol, Δ*S*^o^ = −183.2 ± 0.1 cal/mol K and Δ*G*^o^ = −9.6 ± 0.1 kcal/mol. (D) *Gap-43* 5′GQ RNA probe melting temperature at 5 mM KCl as a function of the RNA concentration. (E) Arrangement of the predicted GQ structure within the *Gap-43* 5′GQ RNA probe. QGRS Mapper software was used for prediction ([@B39]).](518fig6){#F6}

GQ folding within the 5′GQ RNA probe was also analyzed by acquiring CD spectra in the presence of increasing KCl concentrations (5--150 mM). Parallel GQ structures exhibit a positive band at ∼265 nm and a negative band at ∼240 nm, whereas antiparallel GQ structures exhibit a negative band at ∼260 nm and a positive band at ∼295 nm ([@B50]; [@B57]; [@B42]; [@B76]; [@B59]). The 5′GQ RNA probe exhibits the signature of a parallel GQ structure, even in the absence of K^+^ ions ([Figure 6B](#F6){ref-type="fig"}). As KCl levels increased, the intensities of the bands increased, indicating that K^+^ ions drive GQ stability, consistent with the ^1^H NMR spectroscopy results ([Figure 6B](#F6){ref-type="fig"}). However, minimal changes were observed in the spectra upon the increase in salt concentration from 5 to 150 mM, implying that the 5′GQ RNA probe requires low ionic strength to achieve a fully stable GQ structure ([Figure 6B](#F6){ref-type="fig"}).

To obtain information about the stability of the 5′GQ structure, we performed UV spectroscopy thermal denaturation experiments. A main hypochromic transition with a melting temperature (*T*~m~) of 78°C is present in the UV thermal denaturation profile of the 5′GQ RNA probe at 295 nm, corresponding to the GQ dissociation ([Figure 6C](#F6){ref-type="fig"}). The beginning of a second transition is visible above 90°C at high RNA concentrations, likely due to the formation of an alternate intermolecular conformation promoted by high RNA concentrations. To determine whether the 5′GQ RNA probe adopts an intramolecular or intermolecular structure, we performed thermal denaturation experiments at a fixed KCl concentration and variable RNA probe concentration. The melting temperature does not depend on the RNA concentration ([Figure 6D](#F6){ref-type="fig"}), indicating that the 5′GQ RNA probe adopts an intramolecular structure ([Eq. 3](#m3){ref-type="disp-formula"}, *Materials and Methods*). On establishing that the GQ conformation giving rise to the main hypochromic transition in the UV thermal denaturation curve of the 5′GQ RNA probe is intramolecular, we fitted it with [Eq. 4](#m4){ref-type="disp-formula"} (*Materials and Methods*), which assumes a two-state model, to determine the thermodynamic parameters of GQ formation in the presence of 5 mM KCl ([Figure 6C](#F6){ref-type="fig"} inset graph). The enthalpy of formation of a single G-quartet plane has been reported to range between −18 and −25 kcal/mol ([@B33]). Thus the value obtained for the enthalpy of GQ formation in the 5′GQ RNA probe for the main transition (ΔH^0^ = −64.3 ± 0.1 kcal/mol) is consistent with the presence of three G-quartet planes. Taken together, these results suggest that the 5′GQ folds into a stable, parallel, intramolecular GQ structure containing three G-quartet planes ([Figure 6E](#F6){ref-type="fig"}).

hnRNP-Q1 represses endogenous *Gap-43* mRNA translation
-------------------------------------------------------

For determining whether hnRNP-Q1 specifically represses endogenous *Gap-43* mRNA translation, [l]{.smallcaps}-azidohomoalanine (AHA) pulse-labeling experiments were performed ([@B74]). N2a cells were transfected with hnRNP-Q1 \#1 or Scr siRNA; 72 h later, the cells were starved of methionine for 1 h and then pulsed with the methionine analogue AHA for 2 h. AHA combined with the protein synthesis inhibitor anisomycin was used as a control. Excess AHA was washed away, cell lysates were collected, and the Click-iT chemistry reaction was performed to covalently link biotin to AHA that was incorporated into newly synthesized proteins. Endogenous GAP-43 protein was then immunoprecipitated (efficiency shown in Supplemental Figure 6A), and newly synthesized GAP-43 protein was visualized by immunoblot with streptavidin and anti GAP-43 ([Figure 7A](#F7){ref-type="fig"}). hnRNP-Q1 depletion increased AHA GAP-43 protein levels by 2.80-fold, and anisomycin treatment reduced AHA GAP-43 protein levels (Scr: 0.22-fold, Q1: 0.13-fold; [Figure 7B](#F7){ref-type="fig"}). Total AHA-labeled protein levels also increased upon hnRNP-Q1 knockdown (1.62-fold, quantified from 1% input; [Figure 7C](#F7){ref-type="fig"}), suggesting that hnRNP-Q1 regulates a large subset of mRNA transcripts. hnRNP-Q1 knockdown was quantified in Supplemental Figure 6B.

![hnRNP-Q1 represses endogenous *Gap-43* mRNA translation. (A) N2a cells were transfected with hnRNP-Q1 \#1 or Scr siRNA for 72 h, starved of methionine for 1 h, and labeled with the methionine analogue AHA or AHA + anisomycin (Anis) for 2 h. AHA incorporated into newly synthesized proteins was labeled with biotin, endogenous GAP-43 protein was immunoprecipitated, and newly synthesized GAP-43 protein was visualized by immunoblot with streptavidin and anti GAP-43. Top, the streptavidin signal; middle, total GAP-43 and AHA GAP-43/total GAP-43 merged signals; and bottom, α-tubulin signal from 5% input. \*, Nonspecific bands. Quantification of (B) AHA GAP-43 protein levels normalized to total α-tubulin protein levels from 1 or 5% input and (C) total AHA protein levels from 1% input normalized to total α-tubulin protein levels from 1 or 5% input. *n* = 3, two-way ANOVA, Tukey's posthoc, GAP-43 *p* values: Scr + AHA vs. Scr + Anis, *p* \< 0.0001; Scr + AHA vs. Q1 + AHA, *p* \< 0.0001; Scr + AHA vs. Q1 + Anis, *p* \< 0.0001; Scr + Anis vs. Q1 + AHA, *p* \< 0.0001; Scr + Anis vs. Q1 + Anis, *p* = 0.6392; Q1 + AHA vs. Q1 + Anis, *p* \< 0.0001; total *p* values: Scr + AHA vs. Scr + Anis, *p* = 0.0048; Scr + AHA vs. Q1 + AHA, *p* = 0.0188; Scr + AHA vs. Q1 + Anis, *p* = 0.0111; Scr + Anis vs. Q1 + AHA, *p* \< 0.0001; Scr + Anis vs. Q1 + Anis, *p* = 0.9069; Q1 + AHA vs. Q1 + Anis, *p* = 0.0002. (D) N2a cells were transfected with hnRNP-Q1 \#1 or Scr siRNA for 72 h and incubated with or without puromycin (Puro) for 5 min. The cells were fixed, and actively translating GAP-43 and α-tubulin were detected by proximity ligation. Representative images are shown. Scale bar: 10 *μ*m. Quantification of (E) proximity ligation puncta volume/total cell volume and (F) proximity ligation puncta signal intensity/total cell volume. *n* = 3, GAP-43: Scr + Puro, 126 cells; Q1 + Puro, 105 cells; Scr -- Puro, 107 cells; Q1 − Puro, 109 cells; α-tubulin: Scr + Puro, 107 cells; Q1 + Puro, 109 cells; Scr − Puro, 113 cells; Q1 − Puro, 118 cells from three independent experiments, two-way ANOVA, Tukey's posthoc, GAP-43 volume *p* values: Scr + Puro vs. Scr -- Puro, *p* = 0.0419; Scr + Puro vs. Q1 + Puro, *p* \< 0.0001; Scr + Puro vs. Q1 − Puro, *p* = 0.2397; Scr − Puro vs. Q1 + Puro, *p* \< 0.0001; Scr − Puro vs. Q1 − Puro, *p* = 0.8760; Q1 + Puro vs. Q1 − Puro, *p* \< 0.0001; α-tubulin volume *p* values: Scr + Puro vs. Scr − Puro, *p* \< 0.0001; Scr + Puro vs. Q1 + Puro, *p* = 0.9408; Scr + Puro vs. Q1 − Puro, *p* \< 0.0001; Scr − Puro vs. Q1 + Puro, *p* \< 0.0001; Scr − Puro vs. Q1 − Puro, *p* = 0.9826; Q1 + Puro vs. Q1 − Puro, *p* \< 0.0001; GAP-43 intensity *p* values: Scr + Puro vs. Scr − Puro, *p* = 0.0318; Scr + Puro vs. Q1 + Puro, *p* \< 0.0001; Scr + Puro vs. Q1 − Puro, *p* = 0.2403; Scr − Puro vs. Q1 + Puro, *p* \< 0.0001; Scr − Puro vs. Q1 − Puro, *p* = 0.8303; Q1 + Puro vs. Q1 − Puro, *p* \< 0.0001; α-tubulin intensity *p* values: Scr + Puro vs. Scr − Puro, *p* \< 0.0001; Scr + Puro vs. Q1 + Puro, *p* = 0.8904; Scr + Puro vs. Q1 − Puro, *p* \< 0.0001; Scr − Puro vs. Q1 + Puro, *p* \< 0.0001; Scr − Puro vs. Q1 − *Puro*, *p* = 0.9753; Q1 + Puro vs. Q1 − Puro, *p* \< 0.0001.](518fig7){#F7}

Proximity ligation assays were also performed to confirm that hnRNP-Q1 represses endogenous *Gap-43* mRNA translation ([@B18]; [@B74]). N2a cells were transfected with hnRNP-Q1 \#1 or Scr siRNA and Lifeact-GFP; 72 h later, the cells were pulsed with puromycin for 5 min. Media without puromycin was used as a control. Excess puromycin was extracted, the cells were fixed, and proximity ligation reactions were performed with GAP-43 and puromycin antibodies. α-Tubulin and puromycin antibodies were used as a control. The GAP-43 or α-tubulin and puromycin antibodies were bound by secondary antibodies conjugated to oligonucleotides. If a GAP-43 or α-tubulin antibody was within 30--40 nM of the puromycin antibody, which occurred when puromycin was incorporated into a GAP-43 or α-tubulin peptide chain undergoing translation, the oligonucleotides from each secondary antibody were ligated together to form a closed loop. The oligonucleotide loop was then amplified by rolling circle amplification, and fluorescently labeled oligonucleotides were hybridized to the product. Transfected cells were selected by GFP signal ([Figure 7D](#F7){ref-type="fig"}). hnRNP-Q1 knockdown significantly increased both the volume and intensity of GAP-43 proximity ligation puncta (5.30- and 5.13-fold, respectively; [Figure 7, E and F](#F7){ref-type="fig"}), and the no-puromycin controls demonstrated reduced signal (volume: Scr: 0.18-fold, Q1: 0.42-fold; intensity: Scr: 0.19-fold, Q1: 0.45-fold; [Figure 7, E and F](#F7){ref-type="fig"}). However, hnRNP-Q1 knockdown did not affect the volume or intensity of α-tubulin proximity ligation puncta (0.95- and 0.93-fold, respectively; [Figure 7, E and F](#F7){ref-type="fig"}), and the no-puromycin controls demonstrated reduced signal (volume: Scr: 0.19-fold, Q1: 0.22-fold; intensity: Scr: 0.19-fold, Q1: 0.23-fold; [Figure 7, E and F](#F7){ref-type="fig"}). These results further suggest that hnRNP-Q1 represses *Gap-43* mRNA translation but not global translation.

hnRNP-Q1 represses *Gap-43* mRNA translation through the 5′-UTR GQ
------------------------------------------------------------------

AHA pulse-labeling experiments were also performed to determine whether the 5′GQ was involved in hnRNP-Q1--mediated repression of *Gap-43* mRNA translation. To perform these experiments, we first created a construct with the following cassette: *Gap-43* 5′-UTR (with or without 5′GQ)-3×Flag-mCherry-*Gap-43* coding region-*Gap-43* 3′-UTR (FL or Δ5′GQ reporter). N2a cells were transfected with the FL or Δ5′GQ reporter constructs ∼56 h after hnRNP-Q1 \#1 or Scr siRNA transfection. After ∼16 h, the cells were starved of methionine for 1 h and labeled with the methionine analogue AHA for 2 h. AHA incorporated into newly synthesized proteins was labeled with biotin, 3×Flag-mCherry-tagged GAP-43 was immunoprecipitated with anti-Flag agarose beads, and newly synthesized 3×Flag-mCherry-tagged GAP-43 was visualized by immunoblot with streptavidin and anti-Flag ([Figure 8A](#F8){ref-type="fig"}). The results revealed that hnRNP-Q1 depletion increased the translation of the FL reporter by 1.50-fold ([Figure 8B](#F8){ref-type="fig"}). Additionally, the Δ5′GQ reporter was less sensitive to hnRNP-Q1 repression, but hnRNP-Q1 knockdown did significantly increase Δ5′GQ reporter translation (Scr: 2.64-fold, Q1: 3.39-fold; [Figure 8B](#F8){ref-type="fig"}). These findings suggest that hnRNP-Q1 represses *Gap-43* mRNA translation in a 5′GQ-dependent manner but indicate that additional *Gap-43* mRNA sequences, potentially additional GQs, may also contribute to this process. hnRNP-Q1 knockdown was quantified in Supplemental Figure 7A, and a representative example of construct overexpression is shown in Supplemental Figure 7B. In further support of our interpretation of the AHA pulse-labeling experiments, the Δ5′GQ reporter was expressed at a higher basal rate in N2a cells than the FL reporter (1.28-fold; [Figure 8C](#F8){ref-type="fig"}).

![hnRNP-Q1 represses *Gap-43* mRNA translation through the *Gap-43* 5′-UTR GQ sequence. (A) N2a cells were transfected with 3×Flag-mCherry-tagged GAP-43 reporters with (FL) and without (Δ5′GQ) the 5′GQ ∼56 h after hnRNP-Q1 \#1 or Scr siRNA transfection. After ∼16 h, the cells were starved of methionine for 1 h and labeled with the methionine analogue AHA for 2 h. AHA incorporated into newly synthesized proteins was labeled with biotin; 3×Flag-mCherry-tagged GAP-43 was immunoprecipitated; and newly synthesized 3×Flag-mCherry-tagged GAP-43 (predicted to be ∼75 kDa) was visualized by immunoblot with streptavidin and anti-Flag. Top, the streptavidin signal; bottom, total Flag, α-tubulin signal and AHA Flag-GAP-43/Total Flag-GAP-43 merged signals. \*, Nonspecific bands. (B) Quantification of AHA Flag-GAP-43 protein levels normalized to total α-tubulin protein levels from 1 or 5% input. *n* = 6, two-way ANOVA, Holm Sidak's posthoc, *p* values: Scr + FL vs. Scr + ΔGQ, *p* \< 0.0001; Scr + FL vs. Q1 + FL, *p* = 0.0127; Scr + FL vs. Q1 + ΔGQ, *p* \< 0.0001; Scr + ΔGQ vs. Q1 + FL, *p* \< 0.0001; Scr + ΔGQ vs. Q1 + ΔGQ, *p* = 0.0011; Q1 + FL vs. Q1 + ΔGQ, *p* \< 0.0001. (C) The 3×Flag-mCherry--tagged GAP-43 reporter constructs were overexpressed in N2a cells for ∼16 h, and reporter expression was visualized by Flag immunoblot. *n* = 5, one-sample *t* test, *p* value = 0.0177. (D) N2a cells were transfected with hnRNP-Q1 \#1 or Scr siRNA, the 5′ or 5′ΔGQ firefly luciferase construct, and a *Renilla* luciferase construct for normalization. After 72 h, the cells were trypsinized and processed for luciferase activity. *n* = 5, two-way ANOVA, Tukey's posthoc, *p* values: Scr + 5′ vs. Scr + ΔGQ, *p* \< 0.0001; Scr + 5′ vs. Q1 + 5′, *p* = 0.0035; Scr + 5′ vs. Q1 + ΔGQ, *p* \< 0.0001; Scr + ΔGQ vs. Q1 + 5′, *p* \< 0.0001; Scr + ΔGQ vs. Q1 + ΔGQ, *p* = 0.0248; Q1 + 5′ vs. Q1 + ΔGQ, *p* \< 0.0001. (E) N2a cells were transfected with hnRNP-Q1 \#1 or Scr siRNA, the 5′GQ or empty vector firefly luciferase construct, and a *Renilla* luciferase construct for normalization. After 72 h, the cells were trypsinized and processed for luciferase activity. *n* = 6, two-way ANOVA, Holm Sidak's posthoc, *p* values: Scr + E vs. Scr + 5′GQ, *p* = 0.0010; Scr + E vs. Q1 + E, *p* = 0.0543; Scr + E vs. Q1 + 5′GQ, *p* = 0.0694; Scr + 5′GQ vs. Q1 + E, *p* \< 0.0001; Scr + 5′GQ vs. Q1 + 5′GQ, *p* = 0.0492; Q1 + E vs. Q1 + 5′GQ, *p* = 0.0014.](518fig8){#F8}

Luciferase assays were also performed to support the AHA pulse-labeling findings. The *Gap-43* 5′-UTR with or without the 5′GQ sequence was inserted upstream of the firefly luciferase coding region (5′ or 5′ΔGQ constructs). N2a cells were transfected with hnRNP-Q1 \#1 or Scr siRNA, the 5′ or 5′ΔGQ firefly luciferase reporter constructs, and a *Renilla* luciferase construct. Luciferase assays were performed after 72 h. The results revealed that hnRNP-Q1 depletion increased the expression of the 5′ reporter as demonstrated by a 1.57-fold increase in luminescence ([Figure 8D](#F8){ref-type="fig"}). Additionally, the 5′ΔGQ reporter was less sensitive to hnRNP-Q1 repression, but hnRNP-Q1 knockdown did significantly increase 5′ΔGQ reporter expression (Scr: 2.61-fold, Q1: 3.05-fold; [Figure 8D](#F8){ref-type="fig"}). These findings support the results from the AHA pulse-labeling experiments, which suggest that the 5′GQ and likely additional *Gap-43* mRNA sequences contribute to translation inhibition by hnRNP-Q1. Additionally, luciferase assays were performed with a construct that had just the 5′GQ inserted upstream of the firefly luciferase coding region. N2a cells were transfected with hnRNP-Q1 \#1 or Scr siRNA, the 5′GQ or empty vector firefly luciferase reporter constructs and a *Renilla* luciferase construct, and luciferase assays were performed after 72 h. The results demonstrate that inserting only the 5′GQ was sufficient to repress luciferase expression as compared with the empty vector (0.56-fold) and that knocking down hnRNP-Q1 relieves this repression (0.81-fold, [Figure 8E](#F8){ref-type="fig"}). Additionally, expression of the empty vector showed a nonsignificant trend toward being slightly increased upon hnRNP-Q1 knockdown (1.23-fold; [Figure 8E](#F8){ref-type="fig"}) suggesting that the poly(A) tail may contribute to this mechanism ([@B71]), but the effect of the endogenous *Gap-43* poly(A) tail should be assessed before any conclusions can be made. Nonetheless, these findings demonstrate that the 5′GQ is involved in hnRNP-Q1--mediated inhibition of *Gap-43* mRNA translation.

DISCUSSION
==========

In this study, we have identified *Gap-43* mRNA as a novel target that is translationally repressed by the mRNA-binding protein hnRNP-Q1. These findings contribute to the growing literature about the role of hnRNP-Q1 in regulating translation. hnRNP-Q1 has previously been demonstrated to repress cap-dependent translation of *RhoA* and *YB-1* mRNAs ([@B80]; [@B45]). However, the specific mechanism of hnRNP-Q1 binding and translation regulation has yet to be uncovered. Here we further identified a predicted GQ sequence in the 5′-UTR of *Gap-43* mRNA and determined that it folds into a stable, parallel, intramolecular GQ structure. Additionally, this sequence is involved in hnRNP-Q1--mediated translation repression of *Gap-43* mRNA as demonstrated by AHA pulse labeling and luciferase assays. Furthermore, hnRNP-Q1 appears to bind the 5′GQ with higher affinity than poly(A) sequences, and luciferase assays reveal that the poly(A) tail represses expression to a lesser extent than the 5′GQ, suggesting a novel mechanism. In support of this, we have previously demonstrated that hnRNP-Q1 represses RhoA mRNA translation by binding non-poly(A) sequences ([@B80]). We have also demonstrated that, as in other GQ mRNA-binding proteins, the hnRNP-Q1 RGG box domain is sufficient for the recognition of the *Gap-43* 5′GQ. Taken together, these results suggest that hnRNP-Q1 is a novel GQ-binding protein and point to a potential mechanism for hnRNP-Q1--mediated translational regulation. GQs proximal to the 5′ cap have previously been shown to inhibit translation by blocking ribosome assembly or scanning ([@B11]). Therefore hnRNP-Q1 may bind to the 5′GQ of *Gap-43* mRNA and prevent ribosome assembly or scanning. hnRNP-Q1 may repress the translation of *YB-1* by a similar mechanism. *YB-1* mRNA is predicted to contain a GQ with a moderately high G-Score in its 5′-UTR region (G-Score = 20, QGRS Mapper \[ [@B39]\]). In contrast, *RhoA* mRNA translation appears to be regulated in a slightly different manner, because the 3′-UTR is sufficient for hnRNP-Q1--mediated translation repression. However, the 3′-UTR of *RhoA* mRNA also contains a predicted GQ with a high G-Score (G-Score = 41, QGRS Mapper \[ [@B39]\]), and 3′-UTR GQs have also been demonstrated to regulate translation ([@B6]; [@B68]). These findings suggest that GQ structures may be the primary interacting motifs for hnRNP-Q1--mediated translational inhibition. Future studies may address this mechanism in more detail, including identifying the steps needed to repress translation. hnRNP-Q1 may modulate translation through a mechanism similar to FMRP, which interacts with mRNA target GQs when it is phosphorylated at a serine residue near the RGG box domain and is dephosphorylated in order to facilitate translation ([@B13]; [@B53]).

Our results further reveal a novel function for hnRNP-Q1 to control nascent axon and neurite growth in incipient neurons by repressing *Gap-43* translation. At 28.5 h, in vitro neurons are beginning to polarize but do not demonstrate the stereotypical axonal Tau enrichment and dendritic MAP2 enrichment. These results suggest that hnRNP-Q1 plays an important role in regulating nascent axon outgrowth by modulating GAP-43 expression. Similar phenotypes have been reported upon hnRNP-Q knockdown in primary cortical neurons that have undergone Tau and MAP2 expression polarization (3 and 7 d in vitro) suggesting that hnRNP-Q1 functions to regulate neuron morphology at later stages of neuronal development as well ([@B14]). Additionally, we demonstrated that hnRNP-Q1--mediated repression of GAP-43 expression inhibits N2a cell process extension. [@B14] also reported similar N2a phenotypes upon hnRNP-Q1 knockdown but demonstrated that their N2a and neuron phenotypes were due to reduced Cdc42 and associated-factor mRNA localization. However, GAP-43 has been demonstrated to work upstream of both Cdc42 and RhoA to regulate cell morphology, suggesting that hnRNP-Q1 may affect actin cytoskeleton dynamics through the coordinated posttranscriptional regulation of GAP-43, Cdc42, and RhoA expression ([@B1]; [@B29]). These findings suggest that hnRNP-Q1 likely regulates neuron morphology and function by modulating multiple mRNA targets. In support of this, [@B14] performed a microarray analysis for hnRNP-Q1--interacting mRNAs and determined that hnRNP-Q1 interacts with ∼10% of the mRNAs that were interrogated (2250 mRNAs). Additionally, gene ontology analysis reveals that several of the mRNA targets encode proteins involved in neuron and synapse function, protein synthesis, and cytoskeletal regulation ([@B14]). These results suggest that hnRNP-Q1 interacts with and potentially regulates the mRNA localization and/or translation of a specific subset of mRNA targets involved in neuronal development and function. Additionally, [@B14] identified two six-nucleotide hnRNP-Q1 consensus sequences, which expands the list of hnRNP-Q1 *cis*-regulatory elements. hnRNP-Q1 has previously been demonstrated to bind poly(A) RNA ([@B51]; [@B71]), and our findings demonstrate that it can bind GQ structures. More research is needed to determine whether these different *cis*-regulatory elements work cooperatively or allow hnRNP-Q1 to perform different functions. For example, mouse *Gap-43* mRNA also contains multiple consensus sequences and two poly(A) stretches that may potentially bind hnRNP-Q1. Also, whether hnRNP-Q1 regulates different mRNA targets during specific stages of neuronal development has yet to be determined.

hnRNP-Q1 has also been identified as a component of transport mRNP granules and is localized to both the axons and growth cones of primary cortical neurons ([@B7]; [@B38]; [@B14]). Additionally, *Gap-43* mRNA has been detected in the axons and growth cones of differentiated PC12 cells ([@B67]). These findings suggest that *Gap-43* mRNA may be locally translated within axonal growth cones to synthesize new GAP-43 protein in response to axon guidance signals. In support of this, GAP-43 knockdown reduces axon length in dorsal root ganglia neurons, and this phenotype can only be rescued by GAP-43 that is locally translated in axons ([@B23]). Additionally, the AU-rich HuD-binding element is also necessary and sufficient to localize *Gap-43* mRNA to axons, suggesting that HuD and IMP1/ZBP1 work cooperatively to stabilize and localize *Gap-43* mRNA ([@B81]). Our results identify a new factor that regulates GAP-43 expression and suggest that HuD, IMP1/ZBP1, and hnRNP-Q1 may form a complex with *Gap-43* mRNA, enabling the precise control of GAP-43 expression. GAP-43 is also required for netrin-1--induced outgrowth and guidance of neocortical callosal axons ([@B66]), suggesting that netrin-1 modulates GAP-43 function and may increase GAP-43 expression. Interestingly, netrin-1 induces local translation of *β-actin* mRNA in an IMP1/ZBP1-dependent manner ([@B78]), implying that netrin-1 may also play a role in regulating the *Gap-43* mRNA, HuD, IMP1/ZBP1, and hnRNP-Q1 complex. Future studies may address the interplay between HuD, IMP1/ZBP1, and hnRNP-Q1; determine whether these factors regulate GAP-43 expression locally in axonal growth cones; and investigate the role of netrin-1 on this complex. Our results reveal a novel mechanism for regulating GAP-43 expression and further support the idea that a complex of proteins functions to spatially and temporally regulate GAP-43 expression, enabling the growth cone to respond to specific cues during development.

MATERIALS AND METHODS
=====================

Plasmids and siRNA
------------------

Three siRNAs targeting the 3′-UTR of mouse *hnRNP-Q1* mRNA, one targeting the 3′-UTR of mouse *Gap-43* mRNA, and two Scr sequences were purchased from Eurofins (Huntsville, AL) and annealed according to the manufacturer's directions. Sequences for each siRNA are as follows (including 3′ UU overhangs), *hnRNP-Q1 \#1* (sense: 5′-GCAGUUUCAGGUGUAAUCAUU-3′, antisense: 5′- UGAUUACACCUGAAACUGCUU-3′), *hnRNP-Q1 \#2* (sense: 5′- AGCUGGUUAGUCAGGCAUUUU-3′, antisense: 5′-AAUGCCUGACUAACCAG­CUUU-3′), *hnRNP-Q1 \#3* (sense: 5′-GUGUAAGUUUGAGGG­CUA­CUU-3′, antisense: 5′-GUAGCCCUCAAACUUACACUU-3′), *hnRNP-Q1* Scr (sense: 5′-GGCUUGUAGAGCGUAGAGUUU-3′, antisense: 5′- ACUCUACGCUCUACAAGCCUU-3′), *Gap-43* (sense: 5′-GCA­GUCAUCUUGGGAAAUUUU-3′, antisense: 5′-AAUUUCCCAAGAUG­ACUGCUU-3′), and *Gap-43* Scr (sense: 5′-GUUAGUCCGAAUUA­GUCGAUU-3′, antisense: 5′-UCGACUAAUUCGGACUAACUU-3′). shRNA constructs were also generated by inserting the hnRNP-Q1 \#1 or Scr siRNA sequences into the pLentilox3.7 vector under the synapsin promoter and yielded a similar degree of knockdown. The 3×Flag-mCherry-hu hnRNP-Q1 construct was described previously ([@B80]).

Cell culture and transfection
-----------------------------

N2a cells (American Type Culture Collection, Manassas, VA) were grown in DMEM (Sigma-Aldrich, St. Louis, MO) with 10% fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO), 10 mM HEPES (Fisher Scientific, Pittsburgh, PA), 100 U/ml penicillin, and 100 mg/ml streptomycin (Fisher Scientific) at 5% CO~2~ and 37°C. N2a cells for immunofluorescence experiments were plated on coverslips coated with 1 mg/ml poly-[l]{.smallcaps}-lysine (Sigma Aldrich) in borate buffer (40 mM boric acid, 10 mM sodium tetraborate, pH 8.5) for 2 h; this was followed by vigorous washing with sterile H~2~O. N2a cells were transfected with Lipofectamine 2000 (Life Technologies, Carlsbad, CA) according to the manufacturer's protocol. A sample of 100 pmol of siRNA was transfected into cells plated in a 6-well dish and lysed 72 h later for immunoblotting. A sample of 40 pmol of each siRNA and 500 ng Lifeact-GFP or 800 ng shRNA were transfected into cells plated on coverslips in a 12-well dish and fixed 72 h later for immunofluorescence. The medium was changed twice per day for rescue experiments to remove any secreted growth factors.

Timed pregnant C57BL/6J mice were delivered from Charles River, and primary cortical neurons were cultured from the embryos at E16.5. Cortices were dissected from the embryos, trypsinized (0.25%, EDTA-free; Life Technologies) at 37°C, rinsed with warm Hank's balanced salt solution (HBSS) containing 10 mM HEPES (HBSS/HEPES; Fisher Scientific), and dissociated in MEM (Cellgro/Corning, Manassas, VA) containing FBS (MEM/FBS; Sigma-Aldrich). Primary cortical neurons were transfected with the Amaxa nucleofector II device (Lonza, Allendale, NJ) and the mouse neuron nucleofector kit (Lonza) according to the manufacturer's protocol. The neurons were washed with warm HBSS/HEPES immediately following the dissection. A sample of 150 pmol of each siRNA and 2.5 μg Lifeact-GFP were transfected into 5 million cells; this was followed by recovery in RPMI (Life Technologies) containing 10% horse serum (Life Technologies) at 37°C. Cells were plated in MEM/FBS on coverslips previously coated with 1 mg/ml poly-[l]{.smallcaps}-lysine (Sigma-Aldrich) in borate buffer for 72 h; this was followed by three 1-h washes with sterile H~2~O. Two hours after plating, the neurons were cocultured with glia in Neurobasal medium (Life Technologies) with 1× Glutamax (Life Technologies) and 1× B-27 (Life Technologies) at 5% CO~2~ and 37°C and fixed 28.5 h later for immunofluorescence.

Antibodies, immunoblotting, and immunofluorescence
--------------------------------------------------

The following antibodies were used for immunoblotting: hnRNP-Q/R (1:1000; Sigma-Aldrich), GAP-43 (1:5000; Abcam, Cambridge, MA), γ-actin (1:10,000; Santa Cruz, Dallas, TX), α-tubulin (1:50,000; Sigma-Aldrich), IRDye 680LT donkey anti-mouse (1:20,000; Li-Cor, Lincoln, NE), IRDye 800CW donkey anti-mouse (1:20,000; Li-Cor), and IRDye 800CW donkey anti-rabbit (1:20,000, Li-Cor). Immuno­blotting was performed following a standard protocol. Lysates were collected in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, 1% NP-40, 0.5% deoxycholate and 0.1% SDS) supplemented with 1× protease inhibitor (Roche, Indianapolis, IN) and 1× RNase inhibitor (Ambion/Life Technologies) unless otherwise noted, Bradford assays were performed, and equal amounts of protein were run on SDS--PAGE gels. Nitrocellulose membranes were blocked with 5% fraction V bovine serum albumin (BSA; Roche) in 1× phosphate-buffered saline (PBS), and primary and secondary antibody incubations were performed in 5% BSA in 1× PBS with 0.1% Tween 20 at room temperature for 2 and 1 h, respectively. An Odyssey infrared imager and software was used to scan the membranes, and band intensity was quantified using ImageJ. Protein levels were normalized to the loading control α-tubulin.

The following antibodies were used for immunofluorescence: GAP-43 (1:5000; EMD Millipore, Billerica, MA), rhodamine phalloidin (1:1000; Life Technologies), goat anti-mouse Cy3 (1:500; Jackson Immuno Research Laboratories, West Grove, PA), and donkey anti-rabbit Cy5 (1:500, Jackson Immuno Research Laboratories). Additionally, an hnRNP-Q1--specific antibody was produced by immunizing rabbits with a KLH-conjugated peptide corresponding to the C-terminal region of hnRNP-Q1 (KGVEAGPDLLQ, through Anaspec, Freemont, CA). The antibody was affinity purified by the company and delivered at a concentration of 0.076 mg/ml. The hnRNP-Q1 antibody was tested by immunoblotting at 1:300, similar to [@B80] and used for immunofluorescence at 1:100. Immunofluorescence was performed following a standard protocol. Cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) in 1× PBS for 10 min, washed with 1× PBS, permeabilized with 0.2% Triton X-100 in 1× PBS, and washed with Tris-glycine buffer (200 mM Tris-HCl, pH 7.5, 100 mM glycine). Cells were blocked for 1 h, incubated with primary antibody for 1 h, and incubated with secondary antibody for 30 min in 5% BSA in 1× PBS with 0.1% Tween 20 at room temperature. Coverslips were mounted with ProLong Gold Antifade reagent with 4′,6-diamidino-2-phenylindole (Life Technologies).

Fluorescence microscopy
-----------------------

Cells were visualized with a 60× Plan-Neofluar objective (Nikon, Melville, NY) on a Nikon Eclipse inverted microscope. Images were acquired with a cooled CCD camera (Photometrics, Tucson, AZ) and Nikon Elements software. Exposure times were kept constant and below saturation for quantitative analysis. Images were deconvolved using AutoQuant X (Media Cybernetics, Bethesda, MD). GAP-43 and hnRNP-Q1 signal intensities in the cell body and longest neurite of cortical neurons were quantified by thresholding the volume of either cell area with the GFP signal and calculating the mean gray area with ImageJ. The mean gray areas of three in-focus stacks were averaged. Neurites were traced, and neurite number and length were quantified using the NeuronJ plug-in for ImageJ. Neurites were defined as any protrusion longer than 6.4 μm, and the longest neurite was called the nascent axon. Immunofluorescence images were prepared by creating easy three-dimensional images with constant lookup table values across all conditions in Imaris (Bitplane, Concord, MA). Heat maps were prepared in ImageJ by setting the lookup table of 8-bit images to fire.

qRT-PCR experiments
-------------------

RNA was extracted from hnRNP-Q1 \#1-- or Scr siRNA--transfected lysates with TRIzol (Ambion/Life Technologies), and total mRNAs were reverse transcribed into cDNA with superscriptIII reverse transcriptase (Life Technologies) and oligo(dT) primers (Life Technologies) according to the manufacturer's instructions. Real-time PCR was performed with a LightCycler real-time PCR system and LightCycler SYBR Green I reagent (Roche). Primer sequences were as follows: *Gap-43*, 5′-ACAAGATGGTGTCAAGCC-3′ and 5′-CATCGGTAGTAGCAGAGC-3′; and *γ-actin*, 5′-CTGGTGGATCTCTGTGAGCAC-3′ and 5′-AAACGTTCCCAACTCAAGGC-3′.

The dentate gyrus and the remaining region (Ammon's horn) of the hippocampus were dissected from P30 C57BL/6J mice following a standard protocol ([@B32]). Total RNA from each region was extracted with Trizol (Ambion/Life Technologies) and reverse transcribed using random primers (Promega, Madison, WI) and the Quantitect Reverse Transcription Kit with DNase treatment (Qiagen, Valencia, CA). Real-time PCR was performed using Quanta SYBR Green FastMix for iQ kit (Quanta Biosciences, Gaithersburg, MD) in an iQ5 Multicolor Real-Time PCR detection System (Bio-Rad, Hercules, CA). Primer sequences were as follows: *HuD*, 5′-GCAGA­GAAAGCCATCAACACTTTA-3′ and 5′-GCTTCTTCTGCC­TCAATCC­TCT-3′; *Gap-43*, 5′-AGATGGCTCTGCTACTACCGA-3′ and 5′-CCTT­GGAGGACGGGGAGTT-3′; *hnRNP-Q1*, 5′-GTAGA­GCC­GGTTATT­CACAGAG-3′ and 5′-TCATTGTAACAGGTCAGGA­CCG-3′; and *β-actin*, 5′-TGTTACCAACTGGGACGACA-3′ and 5′-GGGGTGTTGAAGGTCTCAAA-3′. Relative quantiﬁcation of each mRNA was determined based on the standard curve generated with the corresponding primers, and all relative concentrations were normalized to *β-actin* mRNA levels as an internal control.

The 3×Flag-mCherry or 3×Flag-mCherry-hu hnRNP-Q1 ([@B80]) constructs were overexpressed in N2a cells for ∼16 h, and Flag-tagged proteins were immunoprecipitated with anti-Flag agarose beads (Sigma-Aldrich). After extensive washing, the pellets were split: one-third for immunoblotting and two-thirds for qRT-PCR. Immunoblots were performed with anti-Flag antibody (1:5000; Sigma-Aldrich) to verify overexpression and immunoprecipitation. Copurifying mRNAs were assessed by qRT-PCR, which was performed as above but also included *Gapdh* primers (5′-GAGTCTACTGGTGTCTTCAC-3′ and 5′-CCACAATGCCAAAGTTGTCAT-3′). mRNA levels with 3×Flag-mCherry immunoprecipitation were inadequate to quantify. mRNA levels with 3×Flag-mCherry-hu hnRNP-Q1 immunoprecipitation were first normalized to the input and then to *γ-actin* mRNA levels.

Biotin pull-down assays
-----------------------

*Gap-43* and *γ-actin* sequences were amplified from mouse brain cDNA; and the *Gap-43* 5′-UTR, coding region, and 3′-UTR were pieced together by overlap extension PCR. The *Gap43* 5′-UTR GQ (5′GQ) sequence was deleted by ordering a forward primer lacking the sequence. All sequences of interest were subcloned into pGEM T-easy (Promega). The constructs were linearized and used as a template for in vitro transcription with T7 or Sp6 Maxiscript kits (Ambion/Life Technologies). Biotin-11-cytidine-5′-triphosphate (Roche) was used in a ratio of 1:4 with unlabeled CTP to produce biotinylated sense RNA probes. Unincorporated nucleotides were removed with G-25 spin columns (GE Healthcare Bio-Sciences, Piscataway, NJ), and the RNA probes were concentrated by ethanol precipitation and resuspended in 10 mM cacodylic acid (pH 6.5). RNA probe concentration was analyzed by A260 absorption, and probe quality was assessed by formaldehyde gel electrophoresis. In vitro--transcribed probes or commercially synthesized RNA oligos with a 5′-end biotin label were annealed by being boiled for 5 min and incubated at room temperature for 15 min and then used for biotin pull-down assays. Recombinant GST or GST-hnRNP-Q1 (∼10 ng, as described in [@B80]) was incubated with equimolar concentrations of RNA probes in the presence of 100 ng/μl yeast tRNA for 20 min at room temperature. NeutrAvidin agarose (Thermo Fisher Scientific, Waltham, MA) preblocked with 20 μg DNase-, RNase-free BSA (Roche) was used to precipitate the biotinylated RNA probes, and copurifying protein was assessed by immunoblotting for GST (1:1000; Covance, Princeton, NJ).

The 3×Flag-mCherry/hu hnRNP-Q1 ΔRGG box and 3×Flag-mCherry/hu hnRNP-Q1 RGG box constructs were generated by amplifying regions of hnRNP-Q1 from 3×Flag-mCherry/hu hnRNP-Q1 construct and inserting them into the 3×Flag-mCherry vector. Sequences for the amplification primers are as follows: ΔRGG box, 5′-CCGGCTCGAGCTATGGCTACA GAACATGTTAATGG-3′ and 5′-CCGGGGTACCTGGAGGGGGCATATGAGG-3′; and RGG box, 5′-CCGGCTCGAGCTACAAGAGGTCGAGGGCG-3′ and 5′-CCGGGGTAC CTCATTGTAACAGGTCAGGACCG-3′. N2a cells were transfected with 2 μg of each 3×Flag-mCherry construct, and the cell lysates were used for biotin pull-down assays as described above after ∼16 h. Copurifying protein was assessed by immunoblotting for Flag (1:5000; Sigma-Aldrich).

Fluorescence spectroscopy experiments
-------------------------------------

Steady-state fluorescence spectroscopy experiments with the 2AP *Gap-43* 5′GQ RNA probe (5′-GGG2APGGGAGGGAGGGA+GAGC-3′) were performed on a Horiba Scientific Fluoromax-4 and accompanying software fitted with a 150-W ozone-free xenon arc lamp. Experiments were performed in a 150 μl sample volume, 3-mm path-length quartz cuvette (Starna Cells, Atascadero, CA). The excitation wavelength was set to 310 nm, the emission spectrum was recorded in the range of 330--450 nm, and the band-pass filters for excitation and emission monochromators were both set to 5 nm. Recombinant hnRNP-Q1 RGG box peptide was synthesized by inserting residues 406--561 into pGEX-2T (GE Healthcare Biosciences), inducing protein synthesis in Rosetta2(DE3)pLysS bacteria (Novagen, Madison, WI), purifying the protein by glutathione affinity, and cleaving off the GST tag with PreScission Protease (GE Healthcare Biosciences). hnRNP-Q1 RGG box peptide was titrated (50 nM) into a fixed concentration of 2AP *Gap-43* 5′GQ RNA (150 nM), and quenching of the fluorescence signal was recorded as a result of the RGG peptide interacting with the RNA probe (each point was corrected for fluorescence contributions originating from the peptide). A concentration of 1 μM of a synthetic peptide derived from the hepatitis C virus core protein was added to the RNA sample before hnRNP-Q1 RGG box peptide titration to prevent nonspecific binding. The binding dissociation constant (*K*~d~) was determined by fitting the binding curves to the equation where *I*~B~/*I*~F~ represents the ratio of the steady-state fluorescence intensity of the bound and free mRNA, \[RNA\]*~t~* is the total concentration of mRNA, and \[*P*\]~t~ is the total peptide concentration.

GQ folding assays
-----------------

The *Gap-43* 5′GQ RNA probe (5′-GGGAGGGAGGGAGGGA+GAGC-3′) and the mutated *Gap-43* 5′GQ RNA probe (5′-GCGAGCGAGCGAGCGA+GAGC-3′) were in vitro transcribed by T7 RNA polymerase--driven transcription of synthetic DNA templates (TriLink BioTechnologies, San Diego, CA). The RNA probes were purified by 20% polyacrylamide, 8 M urea gel electrophoresis and electroelution. Subsequently, the probes were dialyzed against 10 mM cacodylic acid (pH 6.5). The *Gap-43* 5′GQ RNA probe and its mutated version were run on a denaturing polyacrylamide gel with a previously purified *Psd-95* RNA probe (15 nucleotides) to evaluate the purity.

KCl was added to 15 μM of the *Gap-43* 5′GQ RNA probe in the range 0--150 mM. The samples were annealed by being boiled for 5 min; this was followed by incubation at room temperature for 10 min. Twenty percent native gels in 0.5× Tris/borate/EDTA buffer were ran at 100 V for 3 h at 4°C. Probe conformations were visualized by UV shadowing at 254 nm using an AlphaImager (Alpha Innotech, San Leandro, CA).

GQ formation in the *Gap-43* 5′GQ RNA probe was monitored by 1D ^1^H NMR spectroscopy at 25°C on a 500-MHz Bruker AVANCE spectrometer. The 350 μM RNA samples were prepared in 10 mM cacodylic acid buffer (pH 6.5) in a 90% H~2~O/10% D~2~O ratio, and KCl was titrated in the range 0--150 mM. The water suppression was accomplished using the Watergate pulse sequence ([@B58]). Similar experiments were performed for the mutated *Gap-43* 5′GQ RNA probe in the presence and absence of 150 mM KCl to demonstrate that the structure no longer formed when guanine nucleotides predicted to be engaged in GQ formation were mutated.

CD spectra were acquired on a Jasco J-810 spectropolarimeter at 25°C, using a 1-mm path-length quartz cuvette (Starna Cells). A sample of 10 μM *Gap-43* 5′GQ RNA probe in 10 mM cacodylic acid buffer (pH 6.5) was prepared in a volume of 200 μl. GQ formation was monitored between 200 and 350 nm by titrating KCl in the range 5--150 mM and averaging a series of seven scans with a 1-s response time and a 2-nm bandwidth. The spectra were corrected by subtracting the contributions of the cacodylic acid buffer.

UV spectroscopy thermal denaturation experiments were performed on a Cary 3E UV-VIS Spectrophotometer (Varian, Palo Alto, CA) equipped with a peltier cell. Samples of 200 μl containing variable *Gap-43* 5′GQ RNA probe concentrations in 10 mM cacodylic acid buffer (pH 6.5) and in the presence of 5 mM KCl were annealed as described above and thermally denatured by varying the temperature in the range 20--95°C, at a rate of 0.2°C/min and monitoring the absorbance changes at 295 nm, wavelength sensitive to GQ denaturation ([@B49]). A layer of mineral oil was added to the cuvettes to prevent sample evaporation.

To study whether an *intermolecular* or *intramolecular* GQ is formed within *Gap-43* 5′GQ RNA probe, we performed UV spectroscopy thermal denaturation experiments at variable RNA concentrations ranging from 5 to 50 μM and a fixed KCl concentration of 5 mM in 10 mM cacodylic acid buffer (pH 6.5). In case of GQ structure formation between *n* number of RNA strands, the melting temperature (*T*~m~) depends on the total RNA concentration ([Eq. 2](#m2){ref-type="disp-formula"}), whereas the melting temperature of an intramolecular GQ structure (*n* = 1) is independent of the RNA concentration ([Eq. 3](#m3){ref-type="disp-formula"}; [@B33]): where *R* is the gas constant and *ΔH*o~*vH*~ and *ΔS*o~*vH*~ are the Van't Hoff thermodynamic parameters. The thermodynamic parameters of the GQ structure were obtained by fitting the UV thermal denaturation curve to [Eq. 4](#m4){ref-type="disp-formula"}, which assumes a two-state model: where *A~U~* and *A~F~* represent the absorbance of the unfolded and native GQ RNA structure, respectively, and *R* is the universal gas constant.

AHA pulse labeling
------------------

Cells were transfected with 40 pmol hnRNP-Q1 \#1 or Scr siRNA 72 h before being labeled. The cells were washed with room temperature 1× PBS and incubated with DMEM without methionine (DMEM-Met; Life Technologies) for 1 h at 37°C; this was followed by incubation with 100 μg AHA (Life Technologies) or 100 μg AHA + 40 μM anisomycin (Sigma-Aldrich) in DMEM-Met for 2 h at 37°C. The cells were then washed with cold 1× PBS and lysed in 200 μl of Click-iT lysis buffer (50 mM Tris-HCl, pH 8.0, 0.1% SDS) with 1× protease inhibitor on ice. The lysates were sonicated, and 30 μg protein from each condition was used in the Click-iT reaction. The Click-iT protein reaction buffer kit (Life Technologies) and 40 μM biotin alkyne (Life Technologies) were used according to the manufacturer's instructions for the Click-iT reaction. After the Click-iT reaction, 180 μl of each condition was diluted with 820 μl RIPA buffer with 1× protease inhibitor (IP buffer) to stop the Click-iT reaction. GAP-43 antibody (1:50; Abcam) was added to each sample, and the tubes were ­rotated at 4°C for 2 h. Protein G agarose beads (Roche) were resuspended in IP buffer and added to each tube, and tubes were rotated at 4°C for 1 h. After washing, the pellet, a 1% input sample, and a 5% input sample were prepared for immunoblotting for each condition. Newly translated proteins and total GAP-43 protein were detected with IRDye 680LT streptavidin (1:1000; Li-Cor), anti-GAP-43 (1:5000; Abcam), and IRDye 800CW donkey anti-mouse (1:20,000; Li-Cor). α-Tubulin (1:5000; Sigma-Aldrich) was also detected as a loading control.

FL mouse *Gap-43* cDNA with and without the 5′GQ sequence was subcloned into 3×Flag-mCherry in the following order: *Gap-43* 5′-UTR--3×Flag-mCherry--*Gap-43* coding region--*Gap-43* 3′-UTR. AHA-labeling experiments were performed as above except for the following. Samples of 2 μg of the 3×Flag-mCherry-GAP-43 constructs were transfected ∼56 h after siRNA transfection and ∼16 h before AHA labeling, and 100 μg protein from each condition was used in the Click-iT reaction. Anti-Flag agarose beads (Sigma-Aldrich) were resuspended in IP buffer and added to each condition, and the tubes were rotated at 4°C for 2 h. Newly translated proteins and total 3×Flag-mCherry-GAP-43 protein were detected with IRDye 680LT streptavidin (1:1000; Li-Cor), anti-Flag (1:5000; Sigma-Aldrich), and IRDye 800CW donkey anti-mouse (1:20,000; Li-Cor). α-Tubulin (1:5000; Sigma-Aldrich) was also detected as a loading control. N2a cells were transfected with 500 ng of the 3×Flag-mCherry-GAP-43 constructs for ∼16 h to determine whether deleting the 5′GQ sequence causes GAP-43 to have increased expression as detected by immunoblot with anti-Flag (1:5000; Sigma-Aldrich).

Proximity ligation
------------------

Cells were transfected with 40 pmol hnRNP-Q1 \#1 or Scr siRNA 72 h before labeling. The cells were washed with warm DMEM and incubated with DMEM with or without 91 μM puromycin (Sigma-Aldrich) for 5 min at 37°C. Excess puromycin was removed by incubating with cold extraction buffer (50 mM Tris-HCl, pH 7.5, 5 mM MgCl~2~, 25 mM KCl, 0.015% digitonin) for 2 min followed by wash buffer (50 mM Tris-HCl, pH 7.5, 5 mM MgCl~2~, 25 mM KCl) for 2 min. Cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) in 1× PBS for 10 min, washed with 1× PBS, permeabilized with 0.2% Triton X-100 in 1× PBS, and washed with Tris-glycine buffer. Cells were blocked in 5% BSA for 1 h at room temperature and incubated with primary antibodies in 5% BSA for 1 h at room temperature (1:1000 GAP-43 \[Abcam\] + 1:200 puromycin \[Developmental Studies Hybridoma Bank, Iowa City, IA\] or 1:6000 α-tubulin \[Abcam\] + 1:300 puromycin \[Developmental Studies Hybridoma Bank\]). Cells were then washed with 1× PBS, and Duolink proximity ligations were performed according to the manufacturer's protocol (Sigma-Aldrich). Images were analyzed with Imaris (Bitplane). Cell volume was measured by creating a contour surface, and puncta were selected, and their volume and intensity were measured by setting a threshold.

Luciferase assays
-----------------

The mouse *Gap-43* 5′-UTR with and without the 5′GQ sequence or the just 5′GQ sequence (by annealing primers, forward: 5′-AGCTTT​C​A​A​T​C​T​TGGGAGGGAGGGAGGGA​T​C​A​A​T​C​T​TC-3′ and reverse: 5′-CATGGAAGATTGATCCCTCCCTCCCTCCCAAGATTGAA-3′) were subcloned into pGL3 (Promega) upstream of the firefly luciferase coding region with the *Hin*dIII and *Nco*I sites. Cells were transfected with 40 pmol hnRNP-Q1 \#1 or Scr siRNA, 500 ng firefly luciferase construct, and 25 ng *Renilla* luciferase construct (pRL-CMV; Promega). After 72 h, cells were trypsinized and resuspended in fresh DMEM. A measure of 50 μl of cell lysate in triplicate was processed for luciferase activity with the Dual-Glo luciferase assay system (Promega) according to the manufacturer's protocol and a Veritas microplate luminometer (Turner BioSystems/Promega). *Renilla* luminescence was used as an internal control.

Normalization and statistics
----------------------------

hnRNP-Q1 and GAP-43 knockdown immunoblot data were normalized to the internal control α-tubulin and graphed relative to the control condition. hnRNP-Q1 knockdown qRT-PCR data were run in duplicate, and average values were graphed relative to the control condition. Hippocampal qRT-PCR data were normalized to the internal control *β-actin* and graphed relative to the control conditions. hnRNP-Q1 knockdown immunofluorescence and neurite length and number data were normalized to the average control value. The 3×Flag-mCherry-hu hnRNP-Q1 immunoprecipitation qRT-PCR data were first normalized to the input and graphed relative to *γ-actin* mRNA levels. AHA pulse-labeling data were normalized to the internal control α-tubulin and graphed relative to the control condition. Proximity ligation data were normalized to the average control value. Firefly luminescence values were normalized to the internal control *Renilla* luminescence and graphed relative to the control condition. Bar graphs represent the mean ± the SEM. Statistical test and *p* values for each experiment are given in the figure legends.
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